1![EAP Reimbursement Criteria for Frequently Requested Drugs EAP Reimbursement Criteria for Frequently Requested Drugs](https://www.pdfsearch.io/img/d43800678b09c397af0d769297a7df26.jpg) | Add to Reading ListSource URL: www.health.gov.on.caLanguage: English - Date: 2015-08-17 11:45:03
|
---|
2![UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include: Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include: Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol](https://www.pdfsearch.io/img/cb79587767f5e5f3a3010520c40b0ad6.jpg) | Add to Reading ListSource URL: www.ucb-usa.comLanguage: English - Date: 2016-01-20 09:39:34
|
---|
3![RHEUMATOLOGY Rheumatology 2011;50:iv5iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis RHEUMATOLOGY Rheumatology 2011;50:iv5iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis](https://www.pdfsearch.io/img/af3c12724d519de1bc3a9995546ba2f4.jpg) | Add to Reading ListSource URL: rheumatology.oxfordjournals.orgLanguage: English |
---|
4![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. ® HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. ®](https://www.pdfsearch.io/img/95046ce2a224e0235cd7fe8c271fcc35.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2016-04-18 15:38:46
|
---|
5![------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis Recommended dose of XELJANZ is 5 mg twice daily. (2.1) Moderate and severe renal impairment and moderate hepatic impairme ------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis Recommended dose of XELJANZ is 5 mg twice daily. (2.1) Moderate and severe renal impairment and moderate hepatic impairme](https://www.pdfsearch.io/img/f23efa8c5a983e3581cf3bb5d883a435.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2015-06-22 13:44:18
|
---|
6![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. Dermatological toxicity: Interr HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. Dermatological toxicity: Interr](https://www.pdfsearch.io/img/ac7941ce75a15908a4f9c69e5621fab5.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2015-04-14 15:23:06
|
---|
7![542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials 542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials](https://www.pdfsearch.io/img/bf4cbc1b4780738665ca6be098577ca6.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
8![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. ----------------------DOSAGE FORMS AN HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. ----------------------DOSAGE FORMS AN](https://www.pdfsearch.io/img/630598e22887f8daf9afc157c7ad62b9.jpg) | Add to Reading ListSource URL: www.cimzia.comLanguage: English - Date: 2014-10-13 13:03:47
|
---|
9![Important Safety Information you should know about CIMZIA® (certolizumab pegol). What is the most important information I should know about CIMZIA? CIMZIA is a medicine that affects your immune system. CIMZIA can lower Important Safety Information you should know about CIMZIA® (certolizumab pegol). What is the most important information I should know about CIMZIA? CIMZIA is a medicine that affects your immune system. CIMZIA can lower](https://www.pdfsearch.io/img/3719f488b37df28d074d24ca7522bfaf.jpg) | Add to Reading ListSource URL: www.cimzia.comLanguage: English - Date: 2014-10-13 13:03:47
|
---|
10![HIGHLIGHTS OF PRESCRIBING INFORMATION HIGHLIGHTS OF PRESCRIBING INFORMATION](https://www.pdfsearch.io/img/463edb387986ca62c491bcb3b8c8a0e7.jpg) | Add to Reading ListSource URL: www.merck.comLanguage: English - Date: 2015-03-26 19:23:33
|
---|